Evidence map›Paper›PMID 30811281›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Shlomo A Koyfman, Nofisat Ismaila, Doug Crook, Anil D'Cruz, Cristina P Rodriguez, David J Sher, Damian Silbermins, Erich M Sturgis, Terance T Tsue, Jared Weiss and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05144100 (Primary Surgery Vs Primary Chemoradiation for Oropharyngeal Cancer), which is not on this map. Cited by 155 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 10 pooled it
30.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05144100 phase2 / phase3not yet recruitingnot on this mapstarted 2021, after this paper: background citation

Primary Surgery Vs Primary Chemoradiation for Oropharyngeal Cancer (Scope Trial) - A Phase II/III Integrated Design Randomized Control Trial

TypeinterventionalSponsorTata Memorial CentreRan2021 to 2031Enrolled498ConditionsStage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8ArmsSurgery with or without Neck Dissection, Radiation, Cisplatin based chemotherpay
3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 10 syntheses or guidelines pooled it, 370 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Occult lymph node metastasis in the contralateral neck of oropharyngeal squamous cell carcinoma: a meta-analysis and literature review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Pooled it
  10. Pooled it
  11. Predictive value of [European journal of nuclear medicine and molecular imaging · 2025
    Trial
  12. Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Trial
  13. Trial
  14. Submandibular Gland-Sparing Technique Versus En-Bloc Level IB Dissection in Oral Cavity Cancers with N0 Neck Status: A Randomized Controlled Trial.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
    Trial
  15. Article
  16. Article
  17. Quantitative pathological lymph node parameters in head and neck squamous cell carcinoma: a comprehensive analysis of complementary prognostic value in clinically relevant subgroups.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  18. Article
  19. Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 2 countries.

Shlomo A Koyfman1 Cleveland Clinic, Cleveland, OH.
Nofisat Ismaila2 American Society of Clinical Oncology, Alexandria, VA.
Doug Crook3 Patient representative, Indianapolis, IN.
Anil D'Cruz4 Tata Memorial Centre, Mumbai, India.
Cristina P Rodriguez5 University of Washington, Seattle, WA.
David J Sher6 University of Texas Southwestern, Dallas, TX.
Damian Silbermins7 Huntington Internal Medicine Group, Huntington, WV.
Erich M Sturgis8 Anderson Cancer Center, Houston, TX.
Terance T Tsue9 University of Kansas Cancer Center, Kansas City, KS.
Jared Weiss10 University of North Carolina, Chapel Hill, NC.
Sue S Yom11 University of California, San Francisco, San Francisco, CA.
F Christopher Holsinger12 Stanford University, Palo Alto, CA.
American Society of Clinical Oncology · USCleveland Clinic · USHuntington University · USIndianapolis Zoo · USPalo Alto University · USTata Memorial Hospital · INThe University of Kansas Cancer Center · USThe University of Texas MD Anderson Cancer Center · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the current work is to provide evidence-based recommendations to practicing physicians and others on the management of the neck in patients with squamous cell carcinoma of the oral cavity and oropharynx.

methodsASCO convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1990 through 2018. Outcomes of interest included survival, regional disease control, neck recurrence, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.

resultsThe literature search identified 124 relevant studies to inform the evidence base for this guideline. Six clinical scenarios were devised; three for oral cavity cancer and three for oropharynx cancer, and recommendations were generated for each one. RECOMMENDATIONS: For oral cavity cancers, clinical scenarios focused on the indications for and the hallmarks of a high-quality neck dissection, indications for postoperative radiotherapy or chemoradiotherapy, and whether radiotherapy alone is sufficient elective treatment of an undissected neck compared with high-quality neck dissection. For oropharynx cancers, clinical scenarios focused on hallmarks of a high-quality neck dissection, factors that would favor operative versus nonoperative primary management, and clarifying criteria for an incomplete response to definitive chemoradiation for which salvage neck dissection would be recommended. Consensus was reached and recommendations were made for all six clinical scenarios. Additional information is available at www.asco.org/head-neck-cancer-guidelines .

Indexed as

Carcinoma, Squamous CellEvidence-Based MedicineHead and Neck NeoplasmsHumansMedical OncologyMouth NeoplasmsNeck DissectionOropharyngeal NeoplasmsPractice Guidelines as TopicQuality of LifeResearch DesignSocieties, MedicalUnited States

Identifiers

PMID30811281
PMCPMC7098829
OpenAlexW2915388910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.